Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc. is listed in filings as President and CEO at Palvella Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 7, 2025, including 3 public disclosures. Recent filings connect the profile to Palvella Therapeutics, Inc. (PVLA). The current snapshot covers public activity from Feb 7, 2025. Reported amounts are shown as $3.6M to $79.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.